274 related articles for article (PubMed ID: 24954359)
1. The presence of extrathoracic metastasis is more prognostic of survival than Masaoka stage (IVa/IVb) in metastatic thymic epithelial tumor: a retrospective cohort study.
Shin DY; Kim DW; Keam B; Kim TM; Lee SH; Kang CH; Kim YT; Heo DS
Lung Cancer; 2014 Aug; 85(2):320-5. PubMed ID: 24954359
[TBL] [Abstract][Full Text] [Related]
2. Thymoma patients with pleural dissemination: nationwide retrospective study of 136 cases in Japan.
Okuda K; Yano M; Yoshino I; Okumura M; Higashiyama M; Suzuki K; Tsuchida M; Usuda J; Tateyama H
Ann Thorac Surg; 2014 May; 97(5):1743-8. PubMed ID: 24657034
[TBL] [Abstract][Full Text] [Related]
3. A single institutional experience of surgically resected thymic epithelial tumors over 10 years: clinical outcomes and clinicopathologic features.
Kim BK; Cho BC; Choi HJ; Sohn JH; Park MS; Chang J; Kim SK; Kim DJ; Chung KY; Lee CG; Kim JH; Yoo NC
Oncol Rep; 2008 Jun; 19(6):1525-31. PubMed ID: 18497960
[TBL] [Abstract][Full Text] [Related]
4. The potency of curative-intent treatment for advanced thymic carcinoma.
Okuma Y; Horio H; Hosomi Y; Watanabe K; Maeda Y; Okamura T; Hishima T
Lung Cancer; 2014 May; 84(2):175-81. PubMed ID: 24646831
[TBL] [Abstract][Full Text] [Related]
5. Multicenter institutional experience of surgically resected thymic epithelial tumors (TETs): an observational report on behalf of F.O.N.I.C.A.P. (Forza Operativa Nazionale Interdisciplinare Contro il Cancro del Polmone).
Genestreti G; Ampollini L; Burgio MA; Rolli L; Sanna S; Scarpi E; Monti M; Burgio SL; Giannone L; Santo A; Mezzetti M; Casanova C; Buosi R; Rusca M; Amadori D; Gavelli G
Ann Surg Oncol; 2013 Sep; 20(9):2958-63. PubMed ID: 23709100
[TBL] [Abstract][Full Text] [Related]
6. Reproducibility of 3 histologic classifications and 3 staging systems for thymic epithelial neoplasms and its effect on prognosis.
Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Lewis JE; Cassivi SD; Marks RS; Garces YI; Aubry MC
Am J Surg Pathol; 2015 Apr; 39(4):427-41. PubMed ID: 25634747
[TBL] [Abstract][Full Text] [Related]
7. Thymic epithelial tumors: prognostic determinants among clinical, histopathologic, and computed tomography findings.
Moon JW; Lee KS; Shin MH; Kim S; Woo SY; Lee G; Han J; Shim YM; Choi YS
Ann Thorac Surg; 2015 Feb; 99(2):462-70. PubMed ID: 25534526
[TBL] [Abstract][Full Text] [Related]
8. Postoperative radiotherapy is effective for thymic carcinoma but not for thymoma in stage II and III thymic epithelial tumors: the Japanese Association for Research on the Thymus Database Study.
Omasa M; Date H; Sozu T; Sato T; Nagai K; Yokoi K; Okamoto T; Ikeda N; Tanaka F; Maniwa Y;
Cancer; 2015 Apr; 121(7):1008-16. PubMed ID: 25565590
[TBL] [Abstract][Full Text] [Related]
9. GTF2I mutation frequently occurs in more indolent thymic epithelial tumors and predicts better prognosis.
Feng Y; Lei Y; Wu X; Huang Y; Rao H; Zhang Y; Wang F
Lung Cancer; 2017 Aug; 110():48-52. PubMed ID: 28676218
[TBL] [Abstract][Full Text] [Related]
10. Thymoma: inter-relationships among World Health Organization histology, Masaoka staging and myasthenia gravis and their independent prognostic significance: a single-centre experience.
Ruffini E; Filosso PL; Mossetti C; Bruna MC; Novero D; Lista P; Casadio C; Oliaro A
Eur J Cardiothorac Surg; 2011 Jul; 40(1):146-53. PubMed ID: 21093283
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of thymic epithelial tumors according to the new World Health Organization histologic classification.
Park MS; Chung KY; Kim KD; Yang WI; Chung JH; Kim YS; Chang J; Kim JH; Kim SK; Kim SK
Ann Thorac Surg; 2004 Sep; 78(3):992-7; discussion 997-8. PubMed ID: 15337034
[TBL] [Abstract][Full Text] [Related]
12. [TNM classification of thymic epithelial tumors].
Masaoka A; Yamakawa Y
Gan To Kagaku Ryoho; 1997 Apr; 24(6):749-54. PubMed ID: 9126316
[TBL] [Abstract][Full Text] [Related]
13. Modified Masaoka stage and size are independent prognostic predictors in thymoma and modified Masaoka stage is superior to histopathologic classifications.
Roden AC; Yi ES; Jenkins SM; Edwards KK; Donovan JL; Cassivi SD; Marks RS; Garces YI; Aubry MC
J Thorac Oncol; 2015 Apr; 10(4):691-700. PubMed ID: 25629638
[TBL] [Abstract][Full Text] [Related]
14. Clinical evaluation of a new tumour-node-metastasis staging system for thymic malignancies proposed by the International Association for the Study of Lung Cancer Staging and Prognostic Factors Committee and the International Thymic Malignancy Interest Group.
Fukui T; Fukumoto K; Okasaka T; Kawaguchi K; Nakamura S; Hakiri S; Ozeki N; Hirakawa A; Tateyama H; Yokoi K
Eur J Cardiothorac Surg; 2016 Feb; 49(2):574-9. PubMed ID: 26547095
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathological analysis of thymic malignancies with a consistent retrospective database in a single institution: from Tokyo Metropolitan Cancer Center.
Okuma Y; Hosomi Y; Watanabe K; Yamada Y; Horio H; Maeda Y; Okamura T; Hishima T
BMC Cancer; 2014 May; 14():349. PubMed ID: 24885581
[TBL] [Abstract][Full Text] [Related]
16. Masaoka stage and histologic grade predict prognosis in patients with thymic carcinoma.
Hosaka Y; Tsuchida M; Toyabe S; Umezu H; Eimoto T; Hayashi J
Ann Thorac Surg; 2010 Mar; 89(3):912-7. PubMed ID: 20172153
[TBL] [Abstract][Full Text] [Related]
17. Long-term survival and prognostic factors in thymic epithelial tumours.
Rea F; Marulli G; Girardi R; Bortolotti L; Favaretto A; Galligioni A; Sartori F
Eur J Cardiothorac Surg; 2004 Aug; 26(2):412-8. PubMed ID: 15296907
[TBL] [Abstract][Full Text] [Related]
18. [Prognostic factors for thymic epithelial tumor: a retrospective study of 137 cases].
Chen C; Yin B; Wei Q; Hu J; Yu F; Yuan Y; Zhao Y
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2009 Apr; 34(4):340-4. PubMed ID: 19411753
[TBL] [Abstract][Full Text] [Related]
19. Analysis of surgical treatment of Masaoka stage III-IV thymic epithelial tumors.
Hamanaka K; Koyama T; Matsuoka S; Takeda T; Miura K; Yamada K; Hyogotani A; Seto T; Okada K; Ito KI
Gen Thorac Cardiovasc Surg; 2018 Dec; 66(12):731-735. PubMed ID: 30132223
[TBL] [Abstract][Full Text] [Related]
20. A prospective phase II trial of induction chemotherapy with docetaxel/cisplatin for Masaoka stage III/IV thymic epithelial tumors.
Park S; Ahn MJ; Ahn JS; Sun JM; Shim YM; Kim J; Choi YS; Kim K; Shin S; Ahn Y; Kwon OJ; Kim H; Lee SJ; Chang WJ; Park K
J Thorac Oncol; 2013 Jul; 8(7):959-66. PubMed ID: 23722169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
